利用最新计算机科学工具推动核心脏病学发展
本文指出核心脏病学图像分析自动化程度高于CT、MR和超声心动图,且可提供评估冠脉疾病功能、灌注、血流及相关CT数据的多种影像与临床数据。人工智能软件可从全部可用数据中获得综合风险预测与诊断,帮助核心脏病学保持竞争优势并提升临床效用。
要点
- 核心脏病学图像分析已较CT、MR和超声心动图更自动化。
- SPECT/PET报告因附加评估而复杂度增加,需要额外专业知识与时间。
- 人工智能工具可提供超越主观视觉分析和医生脑内数据整合的诊断与风险预测。
核心结论
- 人工智能软件可从所有可用数据中获得综合风险预测和诊断,增强诊断与风险预测能力。
主要发现
- 核心脏病学可获得评估冠脉疾病功能、灌注、血流及相关CT数据的多种影像与临床数据。
- 这些附加评估增加了SPECT/PET报告的整体复杂性,需要额外专业知识与时间。
- 人工智能工具可超越主观视觉分析和医生脑内数据整合所能达到的诊断与风险预测。
临床怎么用
- 可利用人工智能软件整合核心脏病学全部可用数据,生成综合风险预测和诊断。
- 在SPECT/PET报告复杂度增加时,可借助人工智能工具提升临床效用并保持竞争优势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nuclear cardiology has unique advantages compared to other modalities, since the image analysis is already much more automated compared to what is currently clinically performed for CT, MR, or echocardiography imaging. The diverse image and clinical data available to assess coronary disease function, perfusion, flow, and associated CT data provide new opportunities, but logistically these additional assessments increase the overall complexity of SPECT/PET reporting, necessitating additional expertise and time. The advances in artificial intelligence software can be leveraged to obtain comprehensive risk predictions and diagnoses from all available data. They will allow nuclear cardiology to retain competitive edge compared to other modalities and improve its overall clinical utility. These tools will enhance diagnosis and risk prediction beyond what is possible by subjective visual analysis and mental integration of data by physicians.
引用
- Slomka P. Leveraging latest computer science tools to advance nuclear cardiology. J Nucl Cardiol. 2019. PMID: 31489585. doi:10.1007/s12350-019-01873-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。